CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...